Multitarget stool DNA tests cost more than FIT for early colorectal cancer detection, study finds

by

A brief research report compared screening costs per early-detected colorectal cancer (CRC) case among fecal immunochemical tests (FIT), multitarget stool DNA tests (MSDT) and next-generation MSDTs (N-G MSDT).

Leave A Comment

Your email address will not be published. Required fields are marked *